Trial
NCT05238896
BARIcitinib Cognitive Emotional and Neural signaTuRE
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
Baricitinib Oral Tablet [Olumiant]
Why stopped
Difficulties of inclusion in the study following expiry of the experimental treatment. The time required to supply the study treatment is too long to obtain conclusive results at the end of the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-18